Historic Breakthrough: Huntington’s Disease Successfully Treated for First Time

Pioneering Huntington's Treatment

• 💡 A historic breakthrough has been announced: Huntington's disease, a devastating genetic disorder, has been successfully treated for the first time.
• 🧠 The condition is described as a cruel mix of dementia, Parkinson's, and motor neurone disease, progressively destroying brain cells and independence.
• 🎯 A pioneering gene therapy has demonstrated an unprecedented 75% slowing of the disease's progression, according to early trial results.

How the Gene Therapy Works

• 🔬 The treatment involves a one-time gene therapy delivered directly into the brain during a 12 to 18-hour precision neurosurgery.
• 🧬 Scientists use a modified virus to implant DNA that instructs neurons to create microRNA.
• ✅ This microRNA then intercepts the faulty huntingtin protein, which is responsible for killing brain cells, leading to reduced toxic protein levels and protection of neurons.

Promising Trial Results

• 📊 In a trial conducted by biotech company uniQure, involving 29 patients, disease progression slowed by 75% over three years.
• 📈 This means what would normally take one year for the disease to progress now takes four years, indicating a significant therapeutic effect.
• 👏 Biomarker tests showed fewer brain cells dying than expected, and several patients exceeded expectations, with one even returning to work after medical retirement.

Impact and Future Outlook

• 💖 This breakthrough offers life-changing hope for patients and families, such as Jack May-Davis, who carry the Huntington's gene.
• 🚀 uniQure plans to apply for a US license in early 2026, with subsequent launches anticipated in Europe and the UK.
• 🌱 Experts are also preparing prevention trials for young adults who carry the mutation but are not yet symptomatic, aiming to stop the disease before it starts.